Cuoco v. Moritsugu

222 F.3d 99, 2000 WL 1041227
CourtCourt of Appeals for the Second Circuit
DecidedJuly 28, 2000
DocketDocket No. 98-2954
StatusPublished
Cited by2,879 cases

This text of 222 F.3d 99 (Cuoco v. Moritsugu) is published on Counsel Stack Legal Research, covering Court of Appeals for the Second Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Cuoco v. Moritsugu, 222 F.3d 99, 2000 WL 1041227 (2d Cir. 2000).

Opinion

SACK, Circuit Judge:

Plaintiff John Andrew Cuoco brought a pro se action claiming that she was denied estrogen treatments while incarcerated as a pre-trial detainee in the all-male Federal Correctional Institution at Otisville, New York (“FCI Otisville”) in violation of, inter alia, her Fifth, Eighth and Fourteenth Amendment rights. The defendants and their employment at the time suit was instituted are:

J. Michael Quinlan Director, Federal Bureau of Prisons
Kenneth Moritsugu, D. Medical Director, Federal Bureau of Prisons
Gregory L. Hershberger Warden, FCI Otisville
Donald Moore Health Services Administrator, FCI Otisville
Robert D. Barraco, M.D. Chief Medical Officer and Chief of Health Programs, FCI Otisville
Muhamad Malik, M.D. Psychiatrist, FCI Otisville
Martin Salamack, Ph.D. Chief Psychologist, FCI Ot-isville

The United States District Court for the Southern District of New York (Lawrence M. McKenna, Judge) granted a motion to dismiss the complaint as to defendants Hershberger, Moore, Malik, and Salamack. The court declined to grant a motion to dismiss or for summary judgment brought by the remaining three defendants, Barra-co, Moritsugu, and Quinlan (collectively the “Defendants-Appellants”). We conclude that all of the defendants enjoyed either qualified or absolute immunity from suit and were thus entitled to summary judgment. We therefore reverse in part, vacate in part, and remand to the district court for it to enter judgment for all the defendants.

BACKGROUND

According to her detailed, carefully drafted amended pro se complaint, from which we draw the facts for purposes of this appeal, Cuoco was a pre-trial detainee at FCI Otisville beginning September 5, 1991. She was a preoperative male to female transsexual.1 Prior to her arrest, she had been receiving synthetic estrogen treatments under the supervision of a physician to treat her gender identity dyspho-ria or transsexualism.

When Cuoco entered FCI Otisville, she told a physician’s assistant about her condition. She also explained that she had been taking estrogen at dosages that were to be lowered three months later when she was to be operated on to remove her testicles. Cuoco was allowed to keep for self-administration the ten tablets of the hormone she had with her when admitted to the prison.

On September 10, Cuoco left her cell in administrative segregation to meet with [104]*104the defendant Dr. Barraco. As he emerged from his office Barraco asked the corrections officer who had escorted Cuoco to his office whether he had brought “the HE/SHE.” During the course of an ensuing medical interview, Barraco told Cuoco that he knew “absolutely nothing about transsexuals,” and that he had “never diagnosed or treated a transsexual in [his] entire medical career.” He asked Cuoco whether she expected the Bureau of Prisons to give her sex-change surgery and Cuoco responded that she had no “plans to undergo any surgery while incarcerated.” Barraco agreed to renew Cuoco’s prescription for synthetic estrogen, but only at one-quarter the level of her previous dosage.

The Bureau of Prisons Health Services Manual contains a paragraph devoted to treatment of transsexuals.

It is the policy of the Bureau of Prisons to maintain the transsexual inmate at the level of change existing upon admission to the Bureau. Should responsible medical staff determine that either progressive or regressive treatment changes are indicated, these changes must be approved by the [Bureau of Prisons] Medical Director prior to implementation. The use of hormones to maintain secondary sexual characteristics may be continued at approximately the same levels as prior to incarceration, but such use must be approved by the Medical Director.

Bureau of Prisons Health Services Manual, Program Statement 6000.3, § 6803.

A week after the interview, on September 17, Barraco told Cuoco that she would not get any synthetic estrogen because, not yet having undergone surgery, she was not a “true or genuine transsexual.” He said that the Bureau of Prisons policy applied only to “true transsexuals.” He told her that if she wanted hormones nonetheless, she would have to file an administrative remedy form.

In response, Cuoco threatened suicide. The defendant Salamack, chief psychologist at the prison, was then summoned. He attended to Cuoco’s suicide threat but told Cuoco that because he was a psychologist and not a medical doctor, there was nothing he could do about her medication.

Cuoco began to suffer psychological and physical withdrawal symptoms resulting from the termination of the estrogen treatment. On September 20, Cuoco made further suicide threats, in response to which she was placed in a cell in the prison hospital furnished only with a stained mattress on a concrete slab. She was stripped to her underwear and forced to sleep with the lights on in the cold. When she complained of a resulting sore throat, she was told she would spend another day in the cell.

Cuoco had two brief meetings with the defendant Malik, a prison staff psychiatrist, during this period. He refused to discuss her medical problem with her and indicated that he could do nothing about the denial of the estrogen tablets.

Also on September 20, Cuoco filed an informal grievance. Barraco called Bureau of Prisons Medical Director Mori-tsugu to ask for authorization to deny Cuoco’s request for hormone treatment. Moritsugu denied Cuoco’s request by telephone even though, according to Cuoco, he knew or should have known of the withdrawal symptoms that would result.

On September 23, Cuoco complained in writing to Health Services Administrator Moore about the denial of her medication and its implications. Moore did not respond.

On September 24, Barraco told Cuoco that Moore and Warden Hershberger had been apprised of the situation. The following day Cuoco spoke to Hershberger. He refused to hear Cuoco’s complaints, remarking that Cuoco “should act like a man the way God intended.”

After a flurry of legal activity, a disciplinary hearing officer said he would talk to both Hershberger and Barraco about [105]*105the matter. And on October 25, Cuoco’s lawyer sent Hershberger a letter asking about Cuoco’s request for estrogen. There was no response.

Cuoco then filed her complaint. The defendants moved to dismiss it, or, in the alternative, for summary judgment, arguing that they were entitled to absolute immunity or qualified immunity and that the complaint failed to allege their personal involvement in the conduct at issue. They also claimed that there was no evidence in the record to support the assertion that Cuoco was a transsexual, rather than a homosexual who took estrogen for aesthetic purposes. Cuoco did not respond to the motion.

In a November 19, 1992 memorandum and order, the district court, construing the lawsuit’s § 1983 claims as claims under Bivens v. Six Unknown Fed. Narcotics Agents, 403 U.S. 388, 91 S.Ct. 1999, 29 L.Ed.2d 619 (1971), because the defendants were federal rather than state officers, see Kingsley v.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Canale v. Doe
N.D. New York, 2025
Lamb v. Cuomo
698 F. App'x 1 (Second Circuit, 2017)
Knox v. Countrywide Bank
673 F. App'x 31 (Second Circuit, 2016)
Dukes v. New York City Employees' Retirement System
581 F. App'x 81 (Second Circuit, 2014)
Ling Li v. Asphalt Green, Inc.
581 F. App'x 6 (Second Circuit, 2014)
Danser v. Bagir International
571 F. App'x 54 (Second Circuit, 2014)
In re General Electric Co. Securities Litigation
998 F. Supp. 2d 145 (S.D. New York, 2014)
Thorsen v. Sons of Norway
996 F. Supp. 2d 143 (E.D. New York, 2014)
Bell v. Jendell
980 F. Supp. 2d 555 (S.D. New York, 2013)
Cerny v. Rayburn
972 F. Supp. 2d 308 (E.D. New York, 2013)
Mulvihill v. New York
956 F. Supp. 2d 425 (W.D. New York, 2013)
Thomas v. Venditto
925 F. Supp. 2d 352 (E.D. New York, 2013)
Preira v. Bancorp Bank
885 F. Supp. 2d 672 (S.D. New York, 2012)

Cite This Page — Counsel Stack

Bluebook (online)
222 F.3d 99, 2000 WL 1041227, Counsel Stack Legal Research, https://law.counselstack.com/opinion/cuoco-v-moritsugu-ca2-2000.